Showing results (2401-2410 of 3,662) with videos related to

Sort By:
Pageof 367
Breast (Edinburgh, Scotland)|September 4, 2024
Can we counterbalance restricted access to innovation through specialized breast cancer care? The REAL-NOTE studyLeonor Vasconcelos de Matos, Marcio Debiasi, Teresa Gantes Padrão, et al.
Breast (Edinburgh, Scotland)|September 6, 2024
Neoadjuvant chemotherapy for breast cancer in Italy: A Senonetwork analysis of 37,215 patients treated from 2017 to 2022A De Luca, M I Amabile, F Santori, et al.
Breast (Edinburgh, Scotland)|August 24, 2024
Estimating the risk of major adverse cardiac events following radiotherapy for left breast cancer using a modified generalized Lyman normal-tissue complication probability modelTzu-Yu Lai, Yu-Wen Hu, Ti-Hao Wang, et al.
Breast (Edinburgh, Scotland)|June 9, 2024
Extracellular volume measured by whole body CT scans predicts chronic cardiotoxicity in breast cancer patients treated with neoadjuvant therapies based on anthracyclines: A retrospective studyR Rosenfeld, S Riondino, M Cerocchi, et al.
Breast (Edinburgh, Scotland)|May 23, 2024
Impact of the genomic signature of 70-genes for breast cancer in the public system and in supplementary health care in a country of medium socioeconomic developmentFabio Postiglione Mansani, Leonardo Ribeiro Soares, Ruffo de Freitas Junior
Breast (Edinburgh, Scotland)|June 6, 2024
Comprehensive analysis of stereotactic Radiosurgery outcomes in triple-negative breast cancer patients with brain metastases: The influence of immunotherapy and prognostic factorsMenekse Turna, Berna Akkus Yıldırım, Çakır Numanoglu, et al.
Breast (Edinburgh, Scotland)|July 12, 2024
Management and outcomes for older women with early breast cancer treated with primary endocrine therapy (PET)Thomas Hubbard, Georgia Wright, Jenna Morgan, et al.
Breast (Edinburgh, Scotland)|July 6, 2024
DCIS knowledge of women choosing between active surveillance and surgery for low-risk DCISE G Engelhardt, R S J M Schmitz, M A Gerritsma, et al.
Breast (Edinburgh, Scotland)|October 19, 2023
Cost effectiveness of using trastuzumab biosimilars compared to trastuzumab original drugs to treat breast cancer in a hospital settingEric C Barat, Marianne L E Arrii, Annaelle Soubieux-Bourbon, et al.
Breast (Edinburgh, Scotland)|October 9, 2023
Consumer experiences of shame in clinical encounters for breast cancer treatment. "Who do you think you are- Angelina Jolie?"M E Brennan, K Bell, G Hamid, et al.
Pageof 367